| Identification | Back Directory | [Name]
Lenvatinib Impurity 5 | [CAS]
1788901-86-9 | [Synonyms]
Levatinib impurity 10
Lenvatinib Impurity M
6-carbamoyl-4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline 1-oxide
6-Quinolinecarboxamide, 4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-, 1-oxide
Lenvatinib impurity 1 4/Lenvatinib N-Oxide/4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide 1-Oxide | [Molecular Formula]
C21H19ClN4O5 | [MDL Number]
MFCD32182565 | [MOL File]
1788901-86-9.mol | [Molecular Weight]
442.85 |
| Chemical Properties | Back Directory | [density ]
1.54±0.1 g/cm3(Predicted) | [storage temp. ]
-10 to -25°C | [solubility ]
Methanol (Slightly, Heated) | [form ]
Solid | [pka]
13.10±0.70(Predicted) | [color ]
Pale Yellow to Light Yellow | [Major Application]
pharmaceutical small molecule |
| Hazard Information | Back Directory | [Uses]
Lenvatinib N-Oxide is a metabolite of Lenvatinib (L329400) which is an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF and SCF receptors. |
|
|